This test refers to sequence-based genotyping of HIV in human plasma infected with the virus to identify genotypic resistance to Rilpivirine. The assay involves the isolation of HIV RNA from blood plasma and amplification of the protease and reverse transcriptase genes. The PCR product is sequenced and analyzed. Genotypic characteristics of the virus are used to predict resistance to Rilipvirine.
status
ACTIVE
Fully-Specified Name
component
Rilpivirine
property
Susc = Susceptibility
time
Pt = Point in time: To identify measures at a point in time. This is a synonym for “spot” or “random” as applied to urine measurements.
Quick, Current, Complete - www.findacode.com